Screening and characterization of an Annexin A2 binding aptamer that inhibits the proliferation of myeloma cells
Authors:
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81470362, 81560038)
- Hunan Provincial Key Project of Science & Technology Foundation of China (2015JC3010)
- Hunan Provincial Natural Science Foundation (2015JJ4075)
This publication has 32 references indexed in Scilit:
- Annexin A2 Heterotetramer: Structure and FunctionInternational Journal of Molecular Sciences, 2013
- Aptamers: A promising tool for cancer imaging, diagnosis, and therapyJournal of Cellular Biochemistry, 2012
- Annexin II interactions with the annexin II receptor enhance multiple myeloma cell adhesion and growth in the bone marrow microenvironmentBlood, 2012
- Aptamer-conjugated nanomaterials and their applicationsAdvanced Drug Delivery Reviews, 2011
- Pathogenesis of MyelomaAnnual Review of Pathology: Mechanisms of Disease, 2011
- Inhibition of Thrombin Activity with DNA-AptamersBulletin of Experimental Biology and Medicine, 2009
- The RNA aptamer disrupts protein–protein interaction between β‐catenin and nuclear factor‐κB p50 and regulates the expression of C‐reactive proteinFEBS Letters, 2009
- Cell-Specific Aptamer Probes for Membrane Protein Elucidation in Cancer CellsJournal of Proteome Research, 2008
- Selection of DNA aptamers against VEGF165 using a protein competitor and the aptamer blotting methodBiotechnology Letters, 2008
- Pegaptanib sodium for ocular vascular diseaseIndian Journal Of Ophthalmology, 2007